nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—Enzalutamide—CYP2D6—endogenous depression	0.0873	1	CrCbGaD
Nilutamide—POR—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.0467	0.127	CbGpPWpGaD
Nilutamide—POR—adrenal cortex—endogenous depression	0.0459	0.0843	CbGeAlD
Nilutamide—POR—pituitary gland—endogenous depression	0.0371	0.0681	CbGeAlD
Nilutamide—POR—adrenal gland—endogenous depression	0.0331	0.0609	CbGeAlD
Nilutamide—POR—midbrain—endogenous depression	0.0327	0.0601	CbGeAlD
Nilutamide—POR—thyroid gland—endogenous depression	0.032	0.0587	CbGeAlD
Nilutamide—AR—forebrain—endogenous depression	0.0293	0.0538	CbGeAlD
Nilutamide—POR—endocrine gland—endogenous depression	0.0287	0.0528	CbGeAlD
Nilutamide—AR—adrenal cortex—endogenous depression	0.0271	0.0498	CbGeAlD
Nilutamide—POR—cerebellum—endogenous depression	0.0253	0.0465	CbGeAlD
Nilutamide—AR—cardiovascular system—endogenous depression	0.0247	0.0455	CbGeAlD
Nilutamide—AR—pituitary gland—endogenous depression	0.0219	0.0403	CbGeAlD
Nilutamide—POR—brain—endogenous depression	0.0205	0.0378	CbGeAlD
Nilutamide—AR—adrenal gland—endogenous depression	0.0196	0.036	CbGeAlD
Nilutamide—CYP2C8—CYP2E1 reactions—CYP2D6—endogenous depression	0.0194	0.0525	CbGpPWpGaD
Nilutamide—AR—thyroid gland—endogenous depression	0.0189	0.0347	CbGeAlD
Nilutamide—CYP2C9—cardiovascular system—endogenous depression	0.0178	0.0327	CbGeAlD
Nilutamide—CYP2C8—pituitary gland—endogenous depression	0.0177	0.0326	CbGeAlD
Nilutamide—CYP2C19—CYP2E1 reactions—CYP2D6—endogenous depression	0.0173	0.0468	CbGpPWpGaD
Nilutamide—AR—endocrine gland—endogenous depression	0.017	0.0312	CbGeAlD
Nilutamide—AR—nervous system—endogenous depression	0.0159	0.0292	CbGeAlD
Nilutamide—CYP2C9—CYP2E1 reactions—CYP2D6—endogenous depression	0.0157	0.0427	CbGpPWpGaD
Nilutamide—CYP2C19—endocrine gland—endogenous depression	0.0157	0.0289	CbGeAlD
Nilutamide—AR—central nervous system—endogenous depression	0.0153	0.0281	CbGeAlD
Nilutamide—CYP2C8—endocrine gland—endogenous depression	0.0137	0.0252	CbGeAlD
Nilutamide—CYP2C9—endocrine gland—endogenous depression	0.0122	0.0224	CbGeAlD
Nilutamide—AR—brain—endogenous depression	0.0121	0.0223	CbGeAlD
Nilutamide—CYP2C8—Xenobiotics—CYP2D6—endogenous depression	0.012	0.0325	CbGpPWpGaD
Nilutamide—CYP2C8—Tamoxifen metabolism—CYP2D6—endogenous depression	0.0115	0.0313	CbGpPWpGaD
Nilutamide—CYP2C19—Xenobiotics—CYP2D6—endogenous depression	0.0107	0.029	CbGpPWpGaD
Nilutamide—CYP2C19—Tamoxifen metabolism—CYP2D6—endogenous depression	0.0103	0.0279	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptors—NR3C1—endogenous depression	0.00984	0.0267	CbGpPWpGaD
Nilutamide—CYP2C8—brain—endogenous depression	0.00982	0.018	CbGeAlD
Nilutamide—CYP2C9—Xenobiotics—CYP2D6—endogenous depression	0.00976	0.0265	CbGpPWpGaD
Nilutamide—CYP2C9—Tamoxifen metabolism—CYP2D6—endogenous depression	0.00939	0.0255	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—GATA3—endogenous depression	0.00837	0.0227	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.00818	0.0222	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.00795	0.0216	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—NR3C1—endogenous depression	0.00778	0.0211	CbGpPWpGaD
Nilutamide—AR—Regulation of Androgen receptor activity—NR3C1—endogenous depression	0.00754	0.0204	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.0062	0.0168	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—MAOA—endogenous depression	0.00599	0.0162	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL10—endogenous depression	0.0058	0.0157	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—endogenous depression	0.00537	0.0146	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.00513	0.0139	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00498	0.0135	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.00496	0.0134	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.00496	0.0134	CbGpPWpGaD
Nilutamide—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00492	0.0133	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00445	0.0121	CbGpPWpGaD
Nilutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00439	0.0119	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00405	0.011	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00404	0.0109	CbGpPWpGaD
Nilutamide—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.004	0.0108	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.00373	0.0101	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.0036	0.00977	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.0036	0.00976	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL10—endogenous depression	0.00344	0.00932	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00329	0.00891	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.00318	0.00862	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.00306	0.0083	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.00304	0.00825	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00304	0.00824	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00271	0.00735	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00247	0.00671	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00244	0.00662	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00218	0.00591	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP2D6—endogenous depression	0.00214	0.00582	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP2D6—endogenous depression	0.00212	0.00574	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00199	0.00539	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00198	0.00536	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP2D6—endogenous depression	0.00191	0.00519	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP2D6—endogenous depression	0.00189	0.00512	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00177	0.00479	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP2D6—endogenous depression	0.00175	0.00473	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP2D6—endogenous depression	0.00172	0.00467	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—COMT—endogenous depression	0.00163	0.00441	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—MAOA—endogenous depression	0.00161	0.00438	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00161	0.00437	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—COMT—endogenous depression	0.0016	0.00435	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—COMT—endogenous depression	0.00145	0.00393	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—MAOA—endogenous depression	0.00144	0.00391	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—COMT—endogenous depression	0.00143	0.00388	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR3C1—endogenous depression	0.00134	0.00364	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—COMT—endogenous depression	0.00132	0.00359	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—MAOA—endogenous depression	0.00131	0.00356	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—COMT—endogenous depression	0.0013	0.00354	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—POMC—endogenous depression	0.00105	0.00285	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—POMC—endogenous depression	0.000938	0.00254	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—POMC—endogenous depression	0.000855	0.00232	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR3C1—endogenous depression	0.000647	0.00175	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TPH1—endogenous depression	0.000605	0.00164	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TPH1—endogenous depression	0.00054	0.00147	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TPH1—endogenous depression	0.000493	0.00134	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CACNB2—endogenous depression	0.000459	0.00124	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TPH2—endogenous depression	0.000459	0.00124	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—DPYD—endogenous depression	0.000451	0.00122	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CACNA1C—endogenous depression	0.00042	0.00114	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TPH2—endogenous depression	0.00041	0.00111	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CACNB2—endogenous depression	0.00041	0.00111	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000404	0.00109	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—DPYD—endogenous depression	0.000403	0.00109	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CACNA1C—endogenous depression	0.000375	0.00102	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CACNB2—endogenous depression	0.000373	0.00101	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TPH2—endogenous depression	0.000373	0.00101	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—DPYD—endogenous depression	0.000367	0.000996	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2D6—endogenous depression	0.000367	0.000995	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.00036	0.000977	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CACNA1C—endogenous depression	0.000342	0.000926	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000328	0.000891	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2D6—endogenous depression	0.000327	0.000888	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2D6—endogenous depression	0.000299	0.00081	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—COMT—endogenous depression	0.000278	0.000754	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MAOA—endogenous depression	0.000276	0.000748	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—COMT—endogenous depression	0.000248	0.000673	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MAOA—endogenous depression	0.000246	0.000668	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—COMT—endogenous depression	0.000226	0.000613	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MAOA—endogenous depression	0.000225	0.000609	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—POMC—endogenous depression	0.00018	0.000487	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—POMC—endogenous depression	0.00016	0.000435	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—POMC—endogenous depression	0.000146	0.000397	CbGpPWpGaD
